News

elegslab's innovative methodology has been featured in the Journal of the KSME (Vol. 63, No. 6). This article explores the transformative potential of C. elegans models in assessing the safety and efficacy of novel drug candidates, existing pharmaceuticals, and advanced gene therapies. The publication highlights how elegslab integrates cutting-edge Artificial Intelligence (AI), Robotics, and Lab-on-a-Chip technologies to overcome the limitations of traditional drug screening. By leveraging these multi-disciplinary innovations, elegslab is pioneering a new standard for high-throughput, precision-based preclinical evaluations.

https://www.dbpia.co.kr/journal/articleDetail?nodeId=NODE11437976